| Literature DB >> 31036059 |
Muhammad A Saeed1, Ian Beveridge1, Ghazanfar Abbas1, Anne Beasley2, Jenni Bauquier1, Edwina Wilkes3, Caroline Jacobson4, Kris J Hughes3, Charles El-Hage1, Ryan O'Handley5, John Hurley6, Lucy Cudmore7, Peter Carrigan7, Lisa Walter8, Brett Tennent-Brown1, Martin K Nielsen9, Abdul Jabbar10.
Abstract
BACKGROUND: Equine gastrointestinal nematodes (GINs) have been the subject of intermittent studies in Australia over the past few decades. However, comprehensive information on the epidemiology of equine GINs, the efficacy of available anthelmintic drugs and the prevalence of anthelmintic resistance (AR) in Australasia is lacking. Herein, we have systematically reviewed existing knowledge on the horse GINs recorded in Australia, and main aspects of their pathogeneses, epidemiology, diagnoses, treatment and control.Entities:
Keywords: Anthelmintic resistance; Australia; Gastrointestinal nematodes; Horse; Strongyles
Mesh:
Substances:
Year: 2019 PMID: 31036059 PMCID: PMC6489199 DOI: 10.1186/s13071-019-3445-4
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1An overview of the assessment of peer-reviewed literature and the selection criteria used to select studies for this review paper
Gastrointestinal nematodes identified from horses in Australia
| Parasite type/spp. | Location (s) | Prevalence range (%) | Reference |
|---|---|---|---|
| Cyathostomins | |||
| | QLD, NSW, VIC, WA | 4–76 | [ |
| Unidentified cyathostomins | QLD, WA | Up to 49 | [ |
| | QLD, NSW, VIC, WA | Up to 76 | [ |
| | QLD, NSW, VIC, WA | 1–72 | [ |
| | QLD, NSW, VIC | 3–4 | [ |
| | QLD, NSW, VIC, WA | 2–76 | [ |
| | QLD, VIC | 1–11 | [ |
| | QLD, NSW, VIC | 1–15 | [ |
| | QLD, VIC | 2–9 | [ |
| | QLD, NSW, VIC | 1–52 | [ |
| “Strongyles” | QLD, VIC | Up to 52 | [ |
| Strongylins | |||
| | VIC | 7 | [ |
| | QLD, VIC | Up to 2 | [ |
| | QLD, VIC, WA | 3–88 | [ |
| | QLD, VIC, WA | 3–30 | [ |
| Non-strongylids | |||
| | QLD, VIC, QA | 5–66 | [ |
| | QLD, VIC, QA | 2–72 | [ |
| | VIC | 51 | [ |
| | QLD, VIC, QA | 7–26 | [ |
| | NSW, QLD, VIC, QA | 5–58 | [ |
| | QLD, VIC | 6 | [ |
| | QLD | 2 | [ |
Abbreviations: EPG, eggs per gram feces; na, not available/applicable; NSW, New South Wales; SA, South Australia; VIC, Victoria; WA, Western Australia
Anthelmintics used against gastrointestinal nematodes of horses in Australia
| Anthelmintic agent | Dosage (mg/kg)a | Efficacy (FECR %) | Days post-treatment | Parasite | Reference |
|---|---|---|---|---|---|
| Abamectin + praziquantel | 0.2, 2.3 | ≥ 90 | 28 | Strongyles | [ |
| Ivermectin | 0.2 | ≥ 90 | 42 | Cyathostomins | [ |
| 0.2 | ≥ 90 | 42 | Cyathostomins, | [ | |
| 0.2 | ≥ 90 | 42 | Cyathostomins | [ | |
| 0.2 | na | 42 | Strongyles | [ | |
| Ivermectin + praziquantel | 0.2, 1.5 | ≥ 90 | 42 | Cyathostomins, | [ |
| Moxidectin | 0.4 | ≥ 90 | 84 | Cyathostomins | [ |
| 0.4 | ≥ 90 | 42 | Cyathostomins, | [ | |
| 0.4 | ≥ 90 | 84 | Cyathostomins | [ | |
| Moxidectin + praziquantel | 0.4, 2.5 | ≥ 90 | 84 | Strongyles | [ |
| Fenbendazole | 10 | 100 | 49 | Strongylins | [ |
| Oxibendazole | 10 | ≥ 90 | 14 | Cyathostomins | [ |
| 10 | 100 | 49 | Strongylins | [ | |
| Thiabendazole + piperazine + trichlorphon | 44, 125, 40 | 100 | 20 | Cyathostomins | [ |
| Morantel | 9.4 | ≥ 90 | 14 | Cyathostomins | [ |
| 10 | ≥ 90 | 27 | Cyathostomins | [ | |
| 10 | 100 | 49 | Strongylins | [ | |
| 12.5 | 99 | 20 | Cyathostomins | [ | |
| 10 | 100 | 7 | Cyathostomins | [ | |
| Morantel + abamectin | 9, 0.2 | 100 | 56 |
| [ |
| Morantel + oxibendazole + dichlorvos | 10 each | 99 | 27 | Cyathostomins | [ |
| 10 each | 100 | 49 | [ |
aOral route
Abbreviations: FECR, fecal egg count reduction; GINs, gastrointestinal nematodes; na, not applicable/available
Anthelmintic resistance reported in gastrointestinal nematodes of horses from Australia
| Anthelmintic agent | Location | Dosage (mg/kg)a | %FECR (95% CL) | Parasite | Reference |
|---|---|---|---|---|---|
| Cyathostomins | |||||
| Benzimidazole | NSW, VIC | Variable | na | Cyathostomins | [ |
| Cambendazole | NSW | 20; oral | 24 | Cyathostomins | [ |
| Febantel | NSW, VIC | 6; oral | 62 | Cyathostomins | [ |
| NSW | 6; oral | 36 | Cyathostomins | [ | |
| Febantel + trichlorphon | NSW, VIC | 6, 40; oral | 56 | Cyathostomins | [ |
| Fenbendazole | NSW | 10; oral | Up to 0 | Cyathostomins | [ |
| Mebendazole | NSW, VIC | 8.8; oral | 43 | Cyathostomins | [ |
| NSW | 9; oral | 40 | Cyathostomins | [ | |
| Oxfendazole | NSW | 10; oral | Up to 0 (0–na) | Cyathostomins | [ |
| Oxibendazole | NSW | 10; oral | Up to 9 | Cyathostomins | [ |
| Ivermectin | VIC | 0.2; oral | na | strongyles | [ |
| Morantel | NSW | 9.4; oral | Up to 74 (9–na) | Cyathostomins | [ |
| Dichlorvos | NSW | 10; oral | Up to 0 | Cyathostomins, Strongylins | [ |
| Abamectin | NSW | 0.2; oral | Up to -116 | [ | |
| Fenbendazole | NSW | 10; oral | Up to -14 (134–na) |
| [ |
| Ivermectin | NSW | 0.2; oral | 57 | [ | |
| QLD | 0.2; oral | 65 (47-83) |
| [ | |
| NSW | 0.2; oral | Up to 18 (-19–na) |
| [ | |
| Pyrantel | NSW | 6.6; oral | Up to 26 (-49–na) |
| [ |
aOral route
Abbreviations: CL, confidence limits; FECR, fecal egg count reduction; na, not available; NSW, New South Wales; QLD, Queensland; VIC, Victoria